Sobetirome

CAS: 211110-63-3

Ref. TM-T5313

Produktinformation

• Name: Sobetirome
• Synonyme: QRX-431, IACS-010759, GC-1, GC1, GC 1, 2-(4-(4-Hydroxy-3-isopropylbenzyl)-3,5-dimethylphenoxy)acetic acid, 2-[4-[[4-Hydroxy-3-(1-methylethyl)phenyl]methyl]-3,5-dimethylphenoxy]acetic acid, 3,5-Dimethyl-4-(4′-hydroxy-3′-isopropylbenzyl)phenoxyacetic acid, Acetic Acid, 2-[4-[[4-Hydroxy-3-(1-Methylethyl)Phenyl]Methyl]-3,5-Dimethylphenoxy]-, Acetic acid, [4-[[4-hydroxy-3-(1-methylethyl)phenyl]methyl]-3,5-dimethylphenoxy]-, GC 1 (pharmaceutical), Qrx 431, T3 analog GC-1, Thyroid hormone receptor agonist GC-1, Thyroid hormone β-receptor agonist GC-1, [3,5-Dimethyl-4-(4-hydroxy-3-isopropylbenzyl)phenoxy]acetic acid, {4-[4-Hydroxy-3-(Propan-2-Yl)Benzyl]-3,5-Dimethylphenoxy}Acetic Acid

Beschreibung

Sobetirome (IACS-010759) is a selective agonist of thyroid hormone receptor β (TRβ) and binds selectively to TRβ-1 (EC50: 0.16 μM).

• Marke: Targetmol

Chemische Eigenschaften

• Molekulargewicht: 328.4
• Formel: C₂₀H₂₄O₄
• Reinheit: 98.08% - 98.25%
• Farbe/Form: Solid